ArticleMolecular biology reports2021

Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.

Sara Muhammad El-Hanboshy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.